Diabet Med 2009;26:268278
[3] [4] Administered as a once-weekly subcutaneous injection, Wegovy works by mimicking the action of the naturally occurring hormone GLP-1
It is important to recognise that whilst constipation is an expected side effect for some users, persistent or severe symptoms warrant medical review
Conversely, those experiencing diarrhoea or loose stools may need to temporarily moderate insoluble fibre intake whilst maintaining adequate soluble fibre to support gut health
33:25 Minuten) In: Deutschlandfunk-Sendung Forschung aktuell Wissenschaft im Brennpunkt
[86] found that semaglutide, as a GLP-1 analog, can directly act on fat cells, increase the expression of thermogenic genes for browning phenotype maintenance, improve the expression of UCP1, mitochondrial biosynthesis and thermogenic marker, thereby contributing to weight loss